Lloyds Enterprises Limited announced the outcome of its Board Meeting held on February 9, 2026. The Board approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2025. Additionally, the Board granted approval for the private placement issuance of Non-Convertible Debentures (NCDs) up to an aggregate amount of ₹500 crores. The standalone results showed Profit Before Tax of ₹18.31 crores for the quarter, while consolidated results reported a Profit Before Tax of ₹163.15 crores for the same period.
Board Meeting Outcome and Financial Approvals
In compliance with regulatory requirements, the Board of Directors of Lloyds Enterprises Limited met on Monday, February 9, 2026, to consider key business items. The primary approvals included the financial results for the period ending December 31, 2025, and a significant capital raising plan.
Unaudited Financial Results (Standalone)
The Board reviewed and approved the Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2025, alongside the Limited Review Report from the Statutory Auditors. Key standalone highlights for the quarter ended December 31, 2025 (compared to the corresponding previous year period) were:
- Profit/ (Loss) from Operations before Exceptional Items and Tax stood at (₹3.22) crores.
- Profit before Tax for the quarter was ₹18.31 crores.
- Net Profit from ordinary activities after tax for the quarter was ₹16.43 crores.
- Earnings Per Share (Basic and Diluted) for the quarter were (₹0.04).
Unaudited Financial Results (Consolidated)
The consolidated figures indicated stronger performance across the Group for the quarter ended December 31, 2025:
- Profit from Operations before Exceptional Items and Tax was ₹53.53 crores.
- Profit before Tax stood at ₹163.15 crores.
- Net Profit from ordinary activities after tax for the quarter reached ₹126.31 crores.
- Total Comprehensive Income attributable to owners of the parent was ₹57.10 crores for the quarter.
- Basic Earnings Per Share for the quarter were ₹0.78 (on an annualized basis for the year ended March 31, 2025, it was ₹0.97).
Approval for Capital Raise via NCDs
The Board further sanctioned the issuance of Non-Convertible Debentures (“NCDs”) through a Private placement basis. The aggregate amount authorized for issuance is not exceeding ₹500 Crores (Rupees Five Hundred Crore Only), to be raised in one or more tranches, subject to all necessary statutory approvals.
Segmental Performance Overview (Consolidated)
Segment reporting under IND AS 108 detailed the performance across four key areas—Real Estate, Steel, Engineering, and Electrical. For the nine months ended December 31, 2025:
- The Engineering segment reported the highest Segment Result (Profit before Finance costs and Tax) at ₹107.15 crores.
- The Steel segment, despite having significant revenue, registered a Segment Result of ₹8.61 crores for the nine months.
- Total Segment Assets stood at ₹4,055.43 crores as of December 31, 2024, compared to ₹6,121.22 crores as of December 31, 2025.
Corporate Updates and Scheme of Arrangement
The accompanying notes detailed several significant corporate actions completed recently:
- The Board approved a Composite Scheme of Arrangement on December 22, 2025, involving the merger of subsidiaries into the company and the demerger of the Real Estate Business Undertaking into a new entity, Lloyds Realty Limited.
- A material subsidiary, Lloyds Engineering Works Limited, completed the acquisition of an additional 12% equity stake in Techno Industries Private Limited, making TIPL a Wholly Owned Subsidiary effective December 26, 2025.
- The company executed a First and Final Call on partly paid-up equity shares worth ₹19.50 per share (premium included) on January 8, 2026.
- Financial assistance aggregating to ₹361 crore was secured from various lenders to meet balance consideration for share warrants of Lloyds Metals and Energy Limited.
- On February 9, 2026, the company sold its stake in Lloyds Engineering Works Limited via a block deal for ₹49.65 per share.
Source: BSE
